Novavax files for COVID vaccine authorization in UK Ruchika Sharma29 Oct 2021 2:26 PM ISTGaithersburg: Novavax, Inc. has recently announced the completion of its rolling regulatory submission to the U.K. Medicines and Healthcare...
Novavax tumbles after report on COVID vaccine production delay Ruchika Sharma21 Oct 2021 10:00 AM ISTNew Delhi: Shares of Novavax Inc fell 16% after a report from Politico said the company faces significant hurdles in proving it can manufacture its...
Serum Institute, Novavax apply to WHO for emergency use listing of Covid-19 vaccine Ruchika Sharma24 Sept 2021 11:00 AM ISTGaithersburg: Novavax, Inc and Serum Institute of India Pvt. Ltd. (SII), have announced a regulatory submission to the World Health Organization...
Atleast 2 billion COVID vaccine doses to be available in 2022: Novavax Ruchika Sharma12 Sept 2021 10:30 AM ISTNew Delhi: Vaccine developer Novavax Inc said on Friday at least 2 billion doses of its COVID-19 vaccine would be available in 2022.The company,...
Novavax Covid-19 vaccine shows 43 percent efficacy against South African variant Ruchika Sharma8 May 2021 2:25 PM ISTNew Delhi: Novavax Inc's Covid-19 vaccine had efficacy of 43% against infections caused by the South African variant in a group that included people...
Supply shortages delaying full-speed production of COVID-19 vaccine: Novavax Ruchika Sharma14 April 2021 2:57 PM ISTNew Delhi: Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third...
Novavax begins COVID-19 vaccine clinical trial crossover Ruchika Sharma6 April 2021 1:30 PM ISTGaithersburg: Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, has recently announced the...
Novavax confirms high efficacy against original, variant COVID-19 strains in UK, South Africa trials Ruchika Sharma14 March 2021 10:15 AM ISTGaithersburg: Novavax, Inc. has recently announced final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19...
Novavax to provide 1.1 billion COVID-19 vaccine doses for COVAX facility Ruchika Sharma21 Feb 2021 9:45 AM ISTGaithersburg: Novavax, Inc. has recently announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to provide 1.1 billion...
Novavax begins COVID-19 Vaccine Phase 3 trials in US, Mexico Ruchika Sharma29 Dec 2020 10:15 AM ISTNVX-CoV2373 contains a full-length, prefusion spike protein made using Novavax' recombinant nanoparticle technology and the company's proprietary...
Serum Institute, Novavax ink pact for producing over 2 billion vaccine doses Ruchika Sharma16 Sept 2020 1:17 PM ISTNVX-CoV2373 is a stable, prefusion protein made using Novavax' recombinant protein nanoparticle technology and includes Novavax' proprietary Matrix-M...
COVID-19 Vaccine: Novavax initiates Phase IIb trial in South Africa Ruchika Sharma21 Aug 2020 9:00 AM ISTGaithersburg: Novavax, Inc. , a late-stage biotechnology company developing next-generation vaccines for serious infectious...
